Readers may remember late last year when the Trump Administration published the Hospital Outpatient Prospective Payment System (OPPS) Price Transparency final rule which requires hospitals to post the ...

Accordingly, these consumer groups filed a lengthy and nasty complaint at the Federal Trade Commission (FTC) last week charging far ranging wrongs about pharmaceutical companies using social media and ...

When it comes to our health, “collaboration between physicians and biopharmaceutical professionals is essential to improving the care we receive and developing new medicines. Whether it is ...

Legal, Regulatory, and Compliance IssuesOn September 1, 2023, the United States Department of Health and Human Services Office of Inspector General (HHS OIG) started to… ...

Recently, the Centers for Medicare and Medicaid Innovation (CMMI) released its "2024 Report to Congress." The report details the… ...

Recently, the Centers for Medicare and Medicaid Innovation (CMMI) released its "2024 Report to Congress." The report details the… ...

With less than a year into New Jersey’s “gift” ban regulation, Attorney General Gurbir Grewal has signaled that changes to an aggressive regulation enacted on January 15, 2018 are forthcoming. As we ...

Analysis and comparison of the survey results from participants and nonparticipants showed that participants chose evidence-based answers more frequently than nonparticipants to questions related to: ...

The study also found a significant difference in perceived rigor between the low- and high-rigor stimuli and that the rigor manipulations were accurately perceived by participants as low-rigor stimuli ...

On May 3, 2021, Arkansas Governor Asa Hutchinson signed HB1709 into law, which prohibits manufacturers from offering discounts on any insulin product. Under the law, pharmaceutical manufacturer ...

As we have covered numerous times over the past few years, pharmaceutical and medical device manufacturers have been increasingly prosecuted and fined for improper, illegal, and unethical behavior. As ...

A number of large pharmaceutical companies have greatly reduced payments to healthcare professionals for promotional speeches. ProPublica reports that GlaxoSmithKline and Pfizer have dropped their ...